[Metabolic changes in blood oxygen in the human heart under ischemic and reperfusion conditions]

L Pawlicki1, J Zasłonka, J Kedziora

  • 1I Kliniki Chorób Wewnetrznych IMW WAM w Lodzi.

Insights

The St. Thomas cardioplegic solution may protect the heart during coronary artery bypass surgery. It mitigates harmful effects from active oxygen species generated during ischemia and reperfusion.

Area of Science:

  • Cardiovascular Surgery
  • Biochemistry
  • Oxidative Stress

Context:

  • Coronary artery bypass grafting (CABG) involves cardiopulmonary bypass and cardioplegia.
  • Ischemia and reperfusion during CABG can generate harmful reactive oxygen species.
  • Evaluating the efficacy of cardioplegic solutions in mitigating oxidative damage is crucial.

Purpose:

  • To assess the impact of St. Thomas cardioplegic solution on oxidative stress markers during CABG.
  • To measure granulocyte count, superoxide anion generation, and antioxidant enzyme activities (SOD-1, GSH-Px, Cat) in blood during cardiac surgery.
  • To determine malondialdehyde (MDA) concentrations as an indicator of lipid peroxidation.

Summary:

  • Granulocyte counts increased, while superoxide anion generation and SOD-1 activity decreased during ischemia and reperfusion.
  • GSH-Px activity increased in aortic blood during reperfusion, and Cat activity generally diminished.
  • MDA levels showed minimal changes, suggesting the cardioplegic solution may protect against lipid peroxidation.

Impact:

  • The findings suggest that the St. Thomas cardioplegic solution offers myocardial protection against oxidative stress induced by ischemia-reperfusion injury.
  • This research provides biochemical evidence supporting the use of this cardioplegic solution in cardiac surgery.
  • Understanding these biochemical changes can inform strategies to improve patient outcomes after CABG.